Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials.

Medicine (Baltimore) · 2023 · PMC10578773 · PMID 37832051

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Although the guidelines do not recommend nafamostat mesilate for the prevention of PEP, it is still widely used in the clinical practice of prevention or treatment of PEP in Japan, South Korea and other Asian countries, and it has been an increasing trend in recent years.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.